U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

Identifiers
BioSample: SAMN35159595; Sample name: BWH_143_K_pne; SRA: SRS17748722
Organism
Klebsiella pneumoniae
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
isolateBWH_143_K_pne
collected byBrigham and Women's Hospital
collection date2022
geographic locationUSA:Boston
hostHomo sapiens
host diseaseUrinary tract infection
isolation sourceurine
latitude and longitude42.3362 N 71.1067 W
host age42
BioProject
PRJNA278886
Retrieve all samples from this project

Submission
Brigham and Women's Hospital, Jay Worley; 2023-05-18
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
amikacinsusceptible<=2mg/LMICVitekBiomérieux96-Well PlateCLSI
amoxicillin-clavulanic acidsusceptible==8.0/4mg/LMICVitekBiomérieux96-Well PlateCLSI
ampicillinresistant>=32mg/LMICVitekBiomérieux96-Well PlateCLSI
cefazolinresistant>=64mg/LMICVitekBiomérieux96-Well PlateCLSI
cefepimesusceptible==4.0mg/LMICVitekBiomérieux96-Well PlateCLSI
cefoxitinsusceptible<=4mg/LMICVitekBiomérieux96-Well PlateCLSI
ceftazidimeresistant==16.0mg/LMICVitekBiomérieux96-Well PlateCLSI
ceftriaxoneresistant>=64mg/LMICVitekBiomérieux96-Well PlateCLSI
ciprofloxacinintermediate==0.5mg/LMICVitekBiomérieux96-Well PlateCLSI
ertapenemsusceptible<=0.5mg/LMICVitekBiomérieux96-Well PlateCLSI
gentamicinsusceptible<=1mg/LMICVitekBiomérieux96-Well PlateCLSI
levofloxacinintermediate==1.0mg/LMICVitekBiomérieux96-Well PlateCLSI
meropenemsusceptible<=0.25mg/LMICVitekBiomérieux96-Well PlateCLSI
nitrofurantoinresistant==128.0mg/LMICVitekBiomérieux96-Well PlateCLSI
piperacillin-tazobactamsusceptible<=4/4mg/LMICVitekBiomérieux96-Well PlateCLSI
tetracyclineresistant>=16mg/LMICVitekBiomérieux96-Well PlateCLSI
tobramycinsusceptible<=1mg/LMICVitekBiomérieux96-Well PlateCLSI
trimethoprim-sulfamethoxazoleresistant>=16/304mg/LMICVitekBiomérieux96-Well PlateCLSI
Accession:
SAMN35159595
ID:
35159595

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center